Aclarion, Inc. - Warrant (NQ:ACONW)

0.0428 UNCHANGED

Streaming Delayed Price Updated: 12:52 PM EDT, Apr 1, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0428
Bid (Size)	0.0111 (40,000)
Ask (Size)	0.4000 (41,500)
Prev. Close	0.0428
Today's Range	0.0428 - 0.0428
52wk Range	0.0214 - 0.2333
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

November 14, 2024

Via ACCESSWIRE

Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023

February 16, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	+14.4%	+14.4%
1 Month	+17.3%	+17.3%
3 Month	+12.9%	+12.9%
6 Month	+42.7%	+42.7%
1 Year	+40.3%	+40.3%

More News

Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV

October 25, 2022

Via ACCESSWIRE

Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor

October 24, 2022

Via ACCESSWIRE

Aclarion Announces Participation at the NASS 37th Annual Meeting

October 10, 2022

Via ACCESSWIRE

John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor

October 03, 2022

Via ACCESSWIRE

Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain

September 19, 2022

Via ACCESSWIRE

Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan

July 20, 2022

Via ACCESSWIRE

Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan

July 20, 2022

From Aclarion Inc.

Via AccessWire

Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain

June 22, 2022

From Aclarion Inc.

Via AccessWire

Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering

April 26, 2022

From Aclarion Inc.

Via AccessWire

Frequently Asked Questions

Is Aclarion, Inc. - Warrant publicly traded?

Yes, Aclarion, Inc. - Warrant is publicly traded.

What exchange does Aclarion, Inc. - Warrant trade on?

Aclarion, Inc. - Warrant trades on the Nasdaq Stock Market

What is the ticker symbol for Aclarion, Inc. - Warrant?

The ticker symbol for Aclarion, Inc. - Warrant is ACONW on the Nasdaq Stock Market

What is the current price of Aclarion, Inc. - Warrant?

The current price of Aclarion, Inc. - Warrant is 0.0428

When was Aclarion, Inc. - Warrant last traded?

The last trade of Aclarion, Inc. - Warrant was at 04/01/26 12:52 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.